Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-026556

SVP, General Counsel bought 1,088 shares at $9.01 ($9,803)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Oltmans Curtis Gale SVP, General Counsel 2021-06-28 Purchase +1,088 $9.01 $9,803 1,088 D: show line 1 in the form
Open-market purchases · 1,088 sh · avg $9.01 · $9,803
Loading xslF345X03/doc4.xml…